Stryker Instruments — Net Sales decreased by 1.0% to $1.52B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $1.36B to $1.52B. Over 3 years (FY 2021 to FY 2024), Instruments — Net Sales shows an upward trend with a 10.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong demand for the company's surgical hardware and successful penetration into operating rooms, while a decrease may signal market saturation or competitive pressure in the surgical equipment space.
This metric represents the total revenue generated from the sale of surgical instruments and related operating room equi...
Peers in the medical device sector report similar revenue streams under surgical instrumentation or operating room equipment segments, often correlated with hospital capital expenditure cycles.
syk_segment_instruments_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.03B | $1.05B | $1.20B | $1.06B | $1.13B | $1.07B | $1.31B | $1.15B | $1.26B | $1.26B | $1.47B | $1.33B | $1.40B | $1.36B | $1.58B | $1.46B | $1.54B | $1.52B |
| QoQ Change | — | +1.5% | +14.3% | -12.0% | +6.6% | -5.0% | +22.1% | -11.9% | +9.6% | -0.3% | +17.2% | -9.4% | +4.6% | -2.7% | +16.3% | -7.6% | +5.2% | -1.0% |
| YoY Change | — | — | — | — | +8.9% | +1.9% | +8.8% | +8.9% | +11.9% | +17.4% | +12.7% | +16.0% | +10.8% | +8.1% | +7.3% | +9.4% | +10.0% | +11.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.